Home
Market
IPO
Screener
Bundles
Super Investors
Sector
Discover
TickerPlus
Account
Vivek PharmaChem
Consolidated
Standalone
Peers
P&L
Balance Sheet
Cash Flows
Corp. Action
News
Ticker
>
Company
>
Vivek PharmaChem share price
Vivek PharmaChem (India) Ltd.
1.08 K
0
0
The company is currently not listed and is under IPO, so all the data might not be available.
Peer Comparison
View Full Peer Comparison
* The Peers list includes companies operating in the same industry and having comparable market cap.
Ratios
Sales Growth
1 Year
-29.51%
3 Year
14.38%
5 Year
14.21%
Profit Growth
1 Year
-17.34%
3 Year
67.95%
5 Year
45.86%
ROE%
1 Year
14.91%
3 Year
21.74%
5 Year
12.9%
ROCE %
1 Year
14.16%
3 Year
16.6%
5 Year
15.19%
Debt/Equity
0.6502
Price to Cash Flow
0
Interest Cover Ratio
0
CFO/PAT
(5 Yr. Avg.)
0
Strengths
Company has been maintaining healthy ROE of
21.7445014493233
% over the past 3 years.
The company has an efficient Cash Conversion Cycle of
0
days.
Limitations
The company has shown a poor revenue growth of
14.3829609215916
% for the Past 3 years.
Company has low Interest coverage ratio of
0
.
The company has a low EBITDA margin of
0
% over the past 5 years.
Profit & Loss
(All Figures in Cr. Adjusted EPS in Rs.)
PARTICULARS
Mar 2015
Mar 2016
Mar 2019
Mar 2020
Mar 2021
Net Sales
99.1
99.47
134.23
211.18
148.87
Total Expenditure
85.11
83.67
113.73
186.54
130.55
Operating Profit
13.99
15.8
20.5
24.64
18.32
Other Income
0.05
0.24
0.49
0.12
0.65
Interest
4.79
5.93
6.15
7.17
4.86
Depreciation
5.77
6.81
7.93
7.84
7.2
Exceptional Items
0
0
0
0
0
Profit Before Tax
3.48
3.31
6.91
9.75
6.92
Tax
5.06
1.85
-0.51
1.44
0.04
Net Profit
-1.58
1.45
7.42
8.32
6.88
Adjusted EPS (Rs.)
-1.11
1.02
5.2
5.84
4.82
Balance Sheet
(All Figures are in Crores.)
Particulars
Mar 2015
Mar 2016
Mar 2019
Mar 2020
Mar 2021
Equity and Liabilities
Share Capital
14.25
14.25
14.25
14.25
14.25
Total Reserves
1.57
3.02
20.12
28.44
35.31
Borrowings
32.26
38.22
30.49
25.37
25.86
Other N/C liabilities
9.2
10.37
9.27
9.07
7.94
Current liabilities
39.18
40.68
59.86
72.08
40.37
Total Liabilities
96.46
106.53
133.99
149.2
123.73
Assets
Net Block
46.01
59.68
53.85
48.5
41.97
Capital WIP
0
0
0
0
0.02
Intangible WIP
0
0
0
0
0
Investments
0
0
0
0
0
Loans & Advances
3.36
4.1
4.37
2.18
3.3
Other N/C Assets
0.03
0.03
0
0
0
Current Assets
47.05
42.71
75.77
98.52
78.43
Total Assets
96.46
106.53
133.99
149.2
123.73
* Other Non-current Liabilities include Net deferred Liabilities
Cash Flows
(All Figures are in Crores.)
PARTICULARS
Mar 2020
Mar 2021
Profit from operations
9.75
6.92
Adjustment
14.95
11.02
Changes in Assets & Liabilities
-10.28
-7.19
Tax Paid
-1.55
-1.09
Operating Cash Flow
12.87
9.65
Investing Cash Flow
-0.17
-1.16
Financing Cash Flow
-12.26
-3.96
Net Cash Flow
0.44
4.53
Corporate Actions
Dividend
Bonus
Rights
Split
Company News
No Latest News available for this company.
Report us
Last Updated on:
Brief about Vivek PharmaChem
x
Ratio Delete Confirmation
×
Are you sure you want to DELETE
from your ratio list? This will also hide it from all other companies that you analyze.
X